Stay updated on Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.

Latest updates to the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page
- Check2 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the entinostat and pembrolizumab study, including its study details, eligibility criteria, locations, and results, instead of a 403 error.SummaryDifference82%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the study record content remains unavailable.SummaryDifference0.2%

- Check16 days agoChange DetectedA notice appears announcing NIH website changes and linking to transition updates and FAQs. It says NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check23 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check30 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1; the page remains a 403 error screen.SummaryDifference0.2%

- Check50 days agoChange DetectedIntroduces a 403 Forbidden error display with minimal navigation (such as a Home link), indicating that access to the study record is blocked.SummaryDifference22%

Stay in the know with updates to Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.